Highly portable quantitative screening test for prostate-specific antigen at point of care

Prostate cancer (PCa) is the second most diagnosed cancer among men. Targeted PCa screening may decrease PCa-specific mortality. Prostate-specific antigen (PSA) is the most reliable and widely accepted tumor biomarker for screening and monitoring PCa status. However, in many settings, quantification...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Balaji Srinivasan, David M. Nanus, David Erickson, Saurabh Mehta
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/73b22ced6c0e487ab6c08edf45a1f912
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares